Challenges With Judging and Interpreting a Drug’s Launch Price

This commentary explains why comparing a launch price with a value-based price from a cost-effectiveness analysis requires further examination.

Authors

Institutions

Publication Details

Journal
The American Journal of Managed Care
Published
2025-03-24
DOI
https://doi.org/10.37765/ajmc.2025.89715
Primary Topic
Science, Research, and Medicine
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Challenges With Judging and Interpreting a Drug’s Launch Price

Melanie D. Whittington
1 links
The American Journal of Managed Care
Science, Research, and Medicine
article

Challenges With Judging and Interpreting a Drug’s Launch Price

Melanie D. Whittington
article en

Abstract

This commentary explains why comparing a launch price with a value-based price from a cost-effectiveness analysis requires further examination.

The American Journal of Managed CareVol. 31(7)
Embraco (Brazil) (BR)
Openalex Percentile: Top 75%
Science, Research, and Medicine
DOISourceOpenAlex
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Challenges With Judging and Interpreting a Drug’s Launch Price — Melanie D. Whittington · The American Journal of Managed Care (2025) | TGRS Research Map | TGRS